Cleveland, OH, United States of America

Salma Ben-Salem

This inventor holds 1 USPTO granted patent. Top assignee: The Cleveland Clinic Foundation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Salma Ben-Salem. Retrieved from https://idiyas.com/inventor/salma-ben-salem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Salma Ben-Salem: Inventor of Citron Kinase Inhibitors.

Introduction

Salma Ben-Salem is an inventor associated with Cleveland, Ohio, and The Cleveland Clinic Foundation. Her listed patent work concerns compounds designed to inhibit citron kinase, a research area with potential applications in cancer treatment.

Latest Patents

Ben-Salem is credited with 1 patent: “Citron Kinase Inhibitors.” The disclosure describes citron kinase-inhibiting compounds, pharmaceutical compositions containing them, and methods for using them. Proposed uses include treating cancers such as medulloblastoma and prostate cancer.

Career Highlights

The available information identifies Ben-Salem’s work with The Cleveland Clinic Foundation and her contribution to research on potential cancer therapies. The patent disclosure connects her invention to the development of compounds and treatment methods for further investigation.

Collaborations

Her listed coworkers include Shaun R. Stauffer and Hannelore V. Heemers. Their names are associated with the same research and patent context.

Conclusion

Salma Ben-Salem’s listed invention focuses on citron kinase inhibitors and their potential use in cancer treatment, reflecting research conducted in connection with The Cleveland Clinic Foundation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…